Drug Resistance, Multiple, Bacterial
"Drug Resistance, Multiple, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
MeSH Number(s)
G06.099.225.812
G06.225.347.812
G07.690.320.269.347.812
G07.690.320.300.500
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple, Bacterial".
- Biological Sciences [G]
- Microbiological Phenomena [G06]
- Bacterial Physiological Phenomena [G06.099]
- Drug Resistance, Bacterial [G06.099.225]
- Drug Resistance, Multiple, Bacterial [G06.099.225.812]
- Drug Resistance, Microbial [G06.225]
- Drug Resistance, Bacterial [G06.225.347]
- Drug Resistance, Multiple, Bacterial [G06.225.347.812]
- Physiological Phenomena [G07]
- Pharmacological Phenomena [G07.690]
- Drug Resistance [G07.690.320]
- Drug Resistance, Microbial [G07.690.320.269]
- Drug Resistance, Bacterial [G07.690.320.269.347]
- Drug Resistance, Multiple, Bacterial [G07.690.320.269.347.812]
- Drug Resistance, Multiple [G07.690.320.300]
- Drug Resistance, Multiple, Bacterial [G07.690.320.300.500]
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple, Bacterial".
This graph shows the total number of publications written about "Drug Resistance, Multiple, Bacterial" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Multiple, Bacterial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 3 | 6 | 9 |
| 2004 | 6 | 3 | 9 |
| 2005 | 6 | 6 | 12 |
| 2006 | 10 | 3 | 13 |
| 2007 | 8 | 11 | 19 |
| 2008 | 10 | 5 | 15 |
| 2009 | 15 | 8 | 23 |
| 2010 | 10 | 10 | 20 |
| 2011 | 13 | 10 | 23 |
| 2012 | 8 | 11 | 19 |
| 2013 | 12 | 8 | 20 |
| 2014 | 9 | 10 | 19 |
| 2015 | 17 | 8 | 25 |
| 2016 | 21 | 11 | 32 |
| 2017 | 17 | 15 | 32 |
| 2018 | 17 | 15 | 32 |
| 2019 | 20 | 13 | 33 |
| 2020 | 7 | 9 | 16 |
| 2021 | 7 | 10 | 17 |
| 2022 | 0 | 1 | 1 |
Below are the most recent publications written about "Drug Resistance, Multiple, Bacterial" by people in Profiles.
-
Transcriptomics Reveals How Minocycline-Colistin Synergy Overcomes Antibiotic Resistance in Multidrug-Resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2022 03 15; 66(3):e0196921.
-
Prospects for Antibacterial Discovery and Development. J Am Chem Soc. 2021 12 22; 143(50):21127-21142.
-
The vulnerable versatility of Salmonella antibiotic persisters during infection. Cell Host Microbe. 2021 12 08; 29(12):1757-1773.e10.
-
Genomic surveillance of Acinetobacter baumannii in the Philippines, 2013-2014. Western Pac Surveill Response J. 2021 Oct-Dec; 12(4):1-15.
-
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex. Antimicrob Agents Chemother. 2021 10 18; 65(11):e0116421.
-
Plazomicin for the treatment of multidrug-resistant Klebsiella bacteraemia in a patient with underlying chronic kidney disease and acute renal failure requiring renal replacement therapy. BMJ Case Rep. 2021 Aug 19; 14(8).
-
Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system. Antimicrob Resist Infect Control. 2021 08 11; 10(1):118.
-
Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. PLoS One. 2021; 16(8):e0255410.
-
Evolution and emergence of multidrug-resistant Mycobacterium tuberculosis in Chisinau, Moldova. Microb Genom. 2021 08; 7(8).
-
Multi-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies. BMC Public Health. 2021 07 16; 21(1):1412.